NCT04219215View on ClinicalTrials.gov

Acute Hyperbaric Oxygen Treatment Increases Hepatic Insulin Sensitivity and Muscle Reactive Oxygen Species in T2D

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

September 20, 2022

Study Completion Date

September 20, 2022

Conditions
Type 2-diabetes
Interventions
DEVICE

100% O2 in oxygen chamber

Application of 100% O2 in an hyperbaric oxygen chamber

DEVICE

21% O2 in oxygen chamber

Application of ambient air (21% O2) in an hyperbaric oxygen chamber

Trial Locations (1)

40225

German Diabetes Center, Düsseldorf

Sponsors
All Listed Sponsors
lead

German Diabetes Center

OTHER

NCT04219215 - Acute Hyperbaric Oxygen Treatment Increases Hepatic Insulin Sensitivity and Muscle Reactive Oxygen Species in T2D | Biotech Hunter | Biotech Hunter